For clinicians, this study challenges the long-standing habit of avoiding GLP-1 drugs in patients with previous pancreatitis
Semaglutide (Wegovy) recently became the first GLP-1 approved by the FDA to treat adults with MASH with moderate-to-advanced fibrosis, based on the phase 3 ESSENCE trial
While glucagon traditionally raises blood glucose, the concurrent GLP-1 and GIP agonism counterbalances this hyperglycemic effect, allowing retatrutide to achieve net glycemic improvement while harnessing glucagon's catabolic benefits for energy expenditure and liver fat clearance
Dr Sinclair described the presentation in plain clinical terms: abdominal pain, nausea, fatigue, severe jaundice
Low-fat dairy products
Wegovy (for weight management) pens should also be refrigerated, though unopened Wegovy pens may be stored at room temperature not exceeding 86F (30C) for up to 28 days if needed